A few years ago, Dr. Oz shared that his mother was suffering from Alzheimer’s disease. And, at the suggestion of Alzheimer’s expert Dr. Rudy Tanzi, Dr. Oz had his mom taking a variety of vitamins including NAD+ boosting supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Anecdotes). In late July, Dr. Oz interviewed health and wellness expert Dr. Darshan Shah, asked which patients he prescribes NR to, and who benefits the most. Here’s what he said:
Category: Alzheimers
In early August, an article at the Brighter Side discussed a 2022 study suggesting that NAD+ booster Nicotinamide Riboside “NR” (FAQs) (Life Changing Anecdotes) may impact metabolic pathways involved in neurodegenerative diseases like Alzheimer’s. We covered the principal investigator on this study, Dr. Martens, and the results of his study here. So, what studies do we now have demonstrating NR might be helpful for Alzheimer’s patients?
On July 21st, Science published a paper entitled “What is really known about the effects of nicotinamide riboside supplementation in humans“. Below is the authors’ conclusion followed by reaction from Dr. Charles Brenner (FAQs) who discovered Nicotinamide Riboside “NR” (FAQs) (Anecdotes) as an NAD+ precursor vitamin:
On a podcast published this week entitled “An NAD Booster That Improves Cellular Health In The Brain“, Dr. Vilhelm Bohr, a molecular biologist, professor at the University of Copenhagen, and former chief of the Laboratory of Molecular Genetics at the National Institute on Aging (NIA), discussed his Alzheimer’s research, and his enthusiasm for NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). Dr. Bohr’s research reminds us of similar work by Alzheimer’s expert Dr. Rudy Tanzi. The following is an excerpt from Dr. Bohr’s podcast interview (transcript and video below):
If you listened to former White House advisor Andy Slavitt’s recent podcast “Are We on the Verge of Curing Alzheimer’s?“, you learned a lot. But you were also surprised by the way it ended. Slavitt was joined by world renowned Alzheimer’s experts, Dr. Paul Aisen and Dr. Rudy Tanzi. Toward the end of the podcast, Dr. Aisen advised those interested in taking measures to prevent Alzheimer’s that taking supplements made no sense. You’d have expected a response from Dr. Tanzi, since we know he disagrees. But none came. So, we, at RaisingNAD reached out to Dr. Tanzi, and learned that his response to Dr. Aisen was edited out. Fortunately, the folks at Lemonada were kind enough to share Tanzi’s comments with us, which we’ve embedded and transcribed below:
You’re likely aware of the recently published and very encouraging clinical results using NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Anecdotes) in a study relating to Alzheimer’s. If you missed it, you can catch up here and here. Late last week, the lead investigator, Dr. Christopher R. Martens gave a podcast interview to discuss results of his study. Here’s a key excerpt (podcast embedded below):
In late December, Dr. Christopher R. Martens and his team at the University of Delaware published results of a study using NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Anecdotes). The title of their paper is “Oral nicotinamide riboside raises NAD+ and lowers biomarkers of neurodegenerative pathology in plasma extracellular vesicles enriched for neuronal origin“. You can read it HERE. Earlier this week, Dr. Martens was interviewed by MedicalResearch.com wherein he discussed his findings. Here are some excerpts:
Late last year, results of a human clinical study were published supporting the idea that NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Life Changing Anecdotes), upon reaching the brain, can alter the metabolism of certain biological pathways involved in neurodegenerative diseases like Alzheimer’s. For the non-scientist, the following articles (one and two) explain the findings in plain English. For those interested in the science, see the following short video (6 minutes):
During the Q&A portion of last week’s presentation, Parkinson’s expert Dr. Charalampos (Haris) Tzoulis was asked if, based on his ongoing clinical trials studying vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Anecdotes), he had any advice for consumers looking to prevent neurological disorders such as Parkinson’s. Here’s what he said:
Last week, results of a clinical study were released bringing new hope for Alzheimer’s patients: “Our results indicate that treatment of AD patients with CMA (full list) can lead to enhanced cognitive functions and improved clinical parameters associated with phenomics, metabolomics, proteomics and imaging analysis.” While this is clearly encouraging news, we’re quick to defer to the expertise of those better positioned to analyze the study results to tell us what they mean. And there’s no one better than Alzheimer’s expert Dr. Rudy Tanzi — who also happens to be a passionate consumer of one of the CMAs in the latest study, Nicotinamide Riboside “NR” (FAQs) (Reviews).
In a presentation given yesterday entitled “Boosting Resiliency with Nicotinamide Riboside”, NAD+ expert Dr. Charles Brenner talked about vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) as a potential treatment for those suffering from ALS. The following are his key concluding quotes (full video below):
We know there’s significant interest in NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) as a potential treatment for Alzheimer’s Disease (Link). It appears the same can now be said for NR and Parkinson’s. The following are results of a Phase 1 clinical trial published yesterday (Note: A Phase 2 study is already underway):
In a lengthy WebMD piece published earlier today, Lisa Marshall details her father’s depressing decline at the hands of Alzheimer’s disease. Despite her father’s death, Marshall explains there’s reason for hope. Scientists are exploring possible ways of fighting back against Alzheimer’s including the use of NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). Key excerpts from the WebMD piece:
Harvard’s Dr. Rudy Tanzi is a leading expert studying Alzheimer’s disease. He also happens to be a passionate believer in NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). As a result of his lab work, he’s launching a clinical trial looking at NR in individuals with mild cognitive impairment (MCI) and mild Alzheimer’s dementia (AD) (actual start date March 2, 2022). Here’s why:
We know that world renowned Alzheimer’s expert Dr. Rudy Tanzi believes in B3 vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). He takes NR daily, he’s conducting a clinical trial studying NR as a possible treatment for Alzheimer’s, and he also recently recommended it to Dr. Oz’s mother who’s currently suffering from that very debilitating disease. What about NR as a possible treatment for Parkinson’s? There’s reason to believe NR could help. Here’s the latest on a recent Parkinson’s/NR clinical trial out of Norway:
In a segment this week entitled “What Regimen Does Dr. Oz Have His Mother On In Her Battle Against Alzheimer’s?”, Dr. Oz talked to Dr. Rudy Tanzi, Alzheimer’s expert and Professor of Neurology at Harvard. Dr. Tanzi offered a series of recommendations including taking NAD boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews).
In numerous recent interviews (Here and Here), top Harvard Alzheimer’s expert Dr Rudy Tanzi discussed plans to initiate 2 human clinical studies using NAD+ boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews). In one study, Dr Tanzi will focus on Alzheimer’s patients. And in the other, which was posted on ClinicalTrials.gov earlier this week Dr Tanzi will focus on long-haul COVID patients experiencing persistent cognitive and physical symptoms. You may remember that Dr Tanzi knows a lot about NR through both personal supplementation (“I religiously take Tru Niagen“) AND his association with the NFL’s New England Patriots. As a result, many have been eagerly awaiting these two clinical trials. Here’s more on the COVID trial posted earlier this week:
We know that there’s enormous interest in studying Nicotinamide Riboside “NR” (FAQs) (Reviews) in the science community. A quick look at the 50+ ongoing or completed clinical trials says it all. But who are these scientists? Chromadex CEO Rob Fried talked about some of them at the Oppenheimer Health Care Conference yesterday.
A popular YouTube channel called Bestie (3.4m subs) posted a short but substantive video this week with Nicotinamide Riboside “NR” (FAQs) (Reviews) topping a list of “6 Supplements That’ll Help You Build A Better Brain” (Turmeric, Lion’s Mane Mushrooms, Seafood, Vitamin D3). Transcript and video embedded below.
We know that one of the world’s top Alzheimer’s experts recently initiated clinical trials testing vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) on human patients. But what about Parkinson’s disease? Both Dr David Sinclair and Dr Charles Brenner agree that there’s good reason for clinical trials testing NAD boosters on those suffering from neurodegenerative diseases. So, what’s the latest? Dr. Brenner (NAD expert and discoverer of NR as an NAD precursor vitamin) made the following comment on Twitter earlier this week.
Harvard Alzheimer’s Expert Explains Why “I Religiously Take Tru Niagen” (Nicotinamide Riboside “NR”)
In a mid-November podcast appearance, Harvard neuroscientist and Alzheimer’s expert Dr. Rudy Tanzi made a compelling case for supplementing with Nicotinamide Riboside “NR” (FAQs) (Reviews). This week, he joined host Linda Cooper on “The New 100 Longevity Campaign” and shared even more. The following are key quotes.
Since launching this site in mid-2020, the goal has been to learn as much as possible about NAD boosting vitamin supplement Nicotinamide Riboside “NR” (FAQs) (Reviews) in order to determine whether to take it myself. I had MANY questions. What’s NAD? How does elevating NAD levels improve my health? Is NR the best way to elevate NAD. levels? Who else takes NR? And the list goes on. So, I started this quest for answers with a very basic question:
Educating the public about NAD is a monumental challenge. And it’s obviously key to those companies selling NAD boosters. But thanks to Dr. Rhonda Patrick of FoundMyFitness the concept of NAD is much more accessible. Here she is on the Joe Rogan Podcast:
Dr. Charles Brenner (FAQs), who discovered Nicotinamide Riboside “NR” (FAQs) (Reviews) as an NAD boosting vitamin and is actively studying NR’s impact on the treatment of COVID-19 recently joined YOU The Owner’s Manual Podcast (Host Dr. Michael Roizen is Chief Wellness Officer at Cleveland Clinic) to discuss his latest research. Key quotes and podcast embedded below:
Dr. Charles Brenner, who discovered Nicotinamide Riboside “NR” (FAQs) (Reviews) as an NAD boosting vitamin and is actively studying NR’s impact on the treatment of COVID-19 recently joined PRECISIONE: The Healthcast podcast to discuss his latest research. Key quotes and podcast embedded below:
Chromadex CEO Rob Fried appeared on the Habits and Hustle Podcast to discuss his movie career, NAD+, and Nicotinamide Riboside “NR” (FAQs) (Reviews). Key quotes, podcast link, and video embedded below:
Dr. Charles Brenner (FAQs), University of Iowa professor, chief scientific advisor at Chromadex, and discoverer of Nicotinamide Riboside “NR” (FAQs) (Reviews) as an NAD precursor vitamin joined the Ben Greenfield Fitness Podcast to discuss NAD+, NR, and lots more. Key quotes and podcast embedded: